Advertisement
The leading life science news channel in the Nordic region.
Global report - September 5, 2024
In a recent study published in Nature, Swedish researchers demonstrate the role of sex hormones in regulating the immune system. This newfound knowledge explains differences between men and women and can be used to develop new immunological medications according to researchers. A research group led by Karolinska Institutet and Uppsala University It has long been […]
Editor's Pick - September 3, 2024
Sweden's industries have long been celebrated for their innovation and impact, but the life sciences stand out for their remarkable achievements that are unfortunately less visible to the public eye. In this article, Maja Neiman from SwedenBIO explores how we can better showcase these groundbreaking advancements to a broader audience.
Editor's Pick - September 3, 2024
FinVector has emerged as a pioneer in the manufacturing of viral-based gene therapy. The company is this year’s BioFinland Award winner and NLS asked Matthias Krieger, Managing Director, about milestones, gene therapy, and not least, the importance of teamwork.
Editor's Pick - September 3, 2024
Fertram Sigurjonsson's company Kerecis is dedicated to producing and commercializing fish skin for medical purposes. Recently, the company became one of Iceland’s first unicorns when it was acquired by Danish medtech giant Coloplast.
Editor's Pick - September 3, 2024
Malin Parmar, professor and research team leader at Developmental and Regenerative Neurobiology, Lund University, has spent over a decade working with stem cells to produce dopamine as a treatment for Parkinson's disease. After such a dedicated effort, some patients are now participating in clinical trials for stem-cell-based transplants.
Editor's Pick - September 3, 2024
This summer, the Swedish-Danish project DiaUnion, which aims to prevent type 1 diabetes, launched a pioneering screening program – taking this unique cross-border collaboration to the next level.
Biotech Business - September 3, 2024
The European Commission has granted Orphan Medicinal Product Designation (OMPD) to the company’s lead drug candidate CS1 in the rare disease Pulmonary Arterial Hypertension (PAH). “This designation offers significant advantages, including a 10-year market exclusivity period post-authorization and various benefits during the development process, facilitating our efforts to bring CS1 to patients with PAH in […]
Collaboration - September 3, 2024
The Theranostics Trial Center (TTC) at Karolinska University Hospital has been awarded financing from Vinnova to run a new project in precision medicine. By combining image-guided diagnostics and therapy with radioactively labeled target-seeking drugs, the project aims to revolutionize cancer treatment in Sweden. “This grant is a big step for our research and a clear […]
Sponsored content - September 1, 2024
The construction of a new building prompted one of Denmark’s largest pharmacy businesses to invest in Vaisala’s viewLinc Continuous Monitoring System (CMS) to protect the production, handling and storage of medicines. The construction of a new building prompted one of Denmark’s largest pharmacy businesses to invest in Vaisala’s viewLinc Continuous Monitoring System (CMS) to protect […]
Collaboration - August 30, 2024
Business Region Göteborg and AstraZeneca have entered a strategic collaboration with the aim to further strengthen the entire life science sector and create jobs and growth in the region. “In order to strengthen the sector and competitiveness in the Gothenburg region, closer strategic cooperation is needed in the life science area, and AstraZeneca is obviously […]
This site uses cookies